GAMMAGARD LIQUID is a ready-to-use liquid medicine that is given in a vein (intravenously) to treat multifocal motor neuropathy (MMN) in adults.
The first and only FDA approved treatment for adults with MMN
Are you living with weakness from Multifocal Motor Neuropathy (MMN)? Ask your doctor about an IG therapy shown to improve muscle strength and disability in adults with MMN.*
*In a 60-week clinical study with 44 adults with MMN, GAMMAGARD LIQUID was shown to improve or maintain grip strength and disability compared to placebo.
It’s important to talk with your doctor about your personal experience with MMN. Click the link below for an interactive questionnaire designed to create a discussion guide to assist you in speaking to your doctor about the things that matter most to you. Please note, the discussion guide is not intended to diagnose your condition or provide medical advice. To get started, tell us a little about yourself.
The road to diagnosis may have been long and uncertain. For many, diagnosis can bring relief—there’s good news that comes with finally knowing what you have. While it’s not curable, MMN is treatable.
GAMMAGARD LIQUID is the only IVIG that was shown in clinical trials to improve grip strength and disability in MMN.*
*In a 60-week clinical study with 44 adults with MMN, GAMMAGARD LIQUID was shown to improve or maintain grip strength and disability compared to placebo.
GAMMAGARD LIQUID is given on a regular basis, so beginning treatment means you’ll have ongoing communication with your healthcare team. Together, you can actively treat your MMN and redefine how it affects your life.